Metocontin Tab
MRP: ₹0.00
Packaging
10 x 1 TAB
Composition
Metoclopramide 15mg
Company
Modi Mundi Pharma
MRP: ₹0.00
Packaging
10 x 1 TAB
Composition
Metoclopramide 15mg
Company
Modi Mundi Pharma
| Medicine | Company | Price | You Save | |
|---|---|---|---|---|
| No substitutes available. | ||||
Extrapyramidal symptoms, restlessness, drowsiness, anxiety, diarrhoea, hypotension, hypertension, headache, depression, blood disorders (e.g. aganulocytosis, methaemoglobinaemia), hypersensitivity reactions (e.g. bronchospasm, rash), galactorrhoea or related disorders, transient increase in plasma aldosterone levels. Potentially Fatal: Neuroleptic malignant syndrome; cardiac conduction disorders may occur with IV dosage form.
Increased sedative effects with CNS depressants. GI effects antagonised by antimuscarinics and opioids. Reduces absorption of digoxin. Increases absorption of ciclosporin, levodopa, aspirin, paracetamol. Interferes with hypoprolactinaemic effect of bromocriptine. Inhibits serum cholinesterase and prolongs neuromuscular blockade produced by suxamethonium and mivacurium. Potentially Fatal: Serotonin syndrome with sertraline (SSRI).
GI haemorrhage, mechanical obstruction and perforation; phaeochromocytoma; history of seizures
Metoclopramide enhances the motility of the upper GI tract and increases gastric emptying without affecting gastric, biliary or pancreatic secretions. It increases duodenal peristalsis which decreases intestinal transit time, and increases lower oesophageal sphincter tone. It is also a potent central dopamine-receptor antagonist and may also have serotonin-receptor (5-HT3) antagonist properties. Absorption: Rapidly and almost completely absorbed from the GI tract (oral); peak plasma concentrations after 1-2 hr. Distribution: Widely distributed; crosses the blood-brain barrier and placenta; enters breast milk. Metabolism: Extensively hepatic. Excretion: Via urine (as unchanged drug, sulfate or glucuronide conjugates and metabolites), faeces; 4-6 hr (terminal elimination half-life).
Children, elderly. Renal or hepatic impairment, porphyria, epilepsy, Parkinson's disease, history of depression. Ability to drive or operate machineries may be impaired. Pregnancy and lactation. Monitor patients on prolonged therapy. Increased risk of tardive dyskinesia in patients on prolonged or high-dose treatment.
Take orally with food and water, as directed by your physician.
Keep in a cool, dry place away from sunlight and moisture.
This content is for educational purposes only. Please consult your doctor before use.
| Brand Name | Form | Price |
|---|---|---|
| Aconame 100 mg Tablet 10s | TAB | ₹190.00 |
| Dilcontin 60mg Tablet 10s | TAB | ₹0.00 |
| Dilcontin XL 120mg Tablet 10s | TAB | ₹0.00 |
| Dilcontin XL 180 Tablet 10s | TAB | ₹0.00 |
| Dilcontin XL 90mg Tablet 10s | TAB | ₹0.00 |
| Fecontin F Tab | TAB | ₹0.00 |
| Fecontin Z Tab | TAB | ₹0.00 |
| Fenaplus MR Tab | TAB | ₹0.00 |
| Fenaplus RX Tab | TAB | ₹0.00 |
| Fenaplus Tab | TAB | ₹0.00 |
| Indicontin 1.5mg | TAB | ₹0.00 |
| Metocontin Tab | TAB | ₹0.00 |
| Monurol 3gm Sachet | Sachet | ₹417.00 |
| Nitrocontin 2.6mg Tab 25s | TAB | ₹0.00 |
| Nitrocontin 6.4mg Tab 25s | TAB | ₹0.00 |
Written by: SastiMedic Medical Team
Reviewed by: Registered Pharmacist